Charles River Laboratories International, Inc.
Cash Flow Statement
| Line Item | FY2009 | FY2008 |
|---|---|---|
| Operating Activities | ||
| Net Income | $114.4M | $-524.5M |
| Depreciation & Amortization | $90.0M | $86.9M |
| Depreciation | $64.2M | — |
| Amortization | $25.7M | $26.7M |
| Stock-Based Compensation | $23.7M | $24.2M |
| Net Cash from Operating Activities | $215.6M | $275.6M |
| Investing Activities | ||
| Capital Expenditures | $79.9M | $198.6M |
| Business Acquisitions | $83.3M | $69.2M |
| Net Cash from Investing Activities | — | — |
| Financing Activities | ||
| Dividends Paid | — | — |
| Stock Repurchases | $45.9M | $115.1M |
| Net Cash from Financing Activities | — | — |
| Net Change in Cash | $-61.0M | $18.1M |
| Free Cash Flow | $135.7M | $76.9M |